Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Genes Dev ; 29(8): 785-90, 2015 Apr 15.
Article in English | MEDLINE | ID: mdl-25838500

ABSTRACT

The amyloid precursor protein (APP) has garnered considerable attention due to its genetic links to Alzheimer's disease. Death receptor 6 (DR6) was recently shown to bind APP via the protein extracellular regions, stimulate axonal pruning, and inhibit synapse formation. Here, we report the crystal structure of the DR6 ectodomain in complex with the E2 domain of APP and show that it supports a model for APP-induced dimerization and activation of cell surface DR6.


Subject(s)
Amyloid beta-Protein Precursor/chemistry , Amyloid beta-Protein Precursor/metabolism , Models, Molecular , Receptors, Tumor Necrosis Factor/chemistry , Receptors, Tumor Necrosis Factor/metabolism , Animals , Crystallization , Dimerization , HEK293 Cells , Humans , Mice , Protein Binding , Protein Structure, Quaternary , Protein Structure, Tertiary , Signal Transduction
2.
Mol Cell ; 37(5): 643-55, 2010 Mar 12.
Article in English | MEDLINE | ID: mdl-20227369

ABSTRACT

The Tie family of endothelial-specific receptor tyrosine kinases is essential for cell proliferation, migration, and survival during angiogenesis. Despite considerable similarity, experiments with Tie1- or Tie2-deficient mice highlight distinct functions for these receptors in vivo. The Tie2 receptor is further unique with respect to its structurally homologous ligands. Angiopoietin-2 and -3 can function as agonists or antagonists; angiopoietin-1 and -4 are constitutive agonists. To address the role of Tie1 in angiopoietin-mediated Tie2 signaling and determine the basis for the behavior of the individual angiopoietins, we used an in vivo FRET-based proximity assay to monitor Tie1 and -2 localization and association. We provide evidence for Tie1-Tie2 complex formation on the cell surface and identify molecular surface areas essential for receptor-receptor recognition. We further demonstrate that the Tie1-Tie2 interactions are dynamic, inhibitory, and differentially modulated by angiopoietin-1 and -2. Based on the available data, we propose a unified model for angiopoietin-induced Tie2 signaling.


Subject(s)
Angiopoietin-1/metabolism , Angiopoietin-2/metabolism , Endothelial Cells/enzymology , Receptor, TIE-1/metabolism , Receptor, TIE-2/metabolism , Signal Transduction , Cell Line , Cell Membrane/enzymology , Fluorescence Resonance Energy Transfer , Humans , Ligands , Models, Molecular , Mutation , Protein Conformation , Protein Multimerization , Protein Structure, Tertiary , RNA Interference , Receptor Cross-Talk , Receptor, TIE-1/chemistry , Receptor, TIE-1/genetics , Receptor, TIE-2/chemistry , Receptor, TIE-2/genetics , Recombinant Fusion Proteins/metabolism , Structure-Activity Relationship , Time Factors , Transfection
3.
Proc Natl Acad Sci U S A ; 110(36): 14634-9, 2013 Sep 03.
Article in English | MEDLINE | ID: mdl-23959867

ABSTRACT

Eph receptor tyrosine kinases and their ephrin ligands mediate cell signaling during normal and oncogenic development. Eph signaling is initiated in a multistep process leading to the assembly of higher-order Eph/ephrin clusters that set off bidirectional signaling in interacting cells. Eph and ephrins are divided in two subclasses based on their abilities to bind and activate each other and on sequence conservation. EphA4 is an exception to the general rule because it can be activated by both A- and B-class ephrin ligands. Here we present high-resolution structures of the complete EphA4 ectodomain and its complexes with ephrin-A5. The structures reveal how ligand binding promotes conformational changes in the EphA4 ligand-binding domain allowing the formation of signaling clusters at the sites of cell-cell contact. In addition, the structural data, combined with structure-based mutagenesis, reveal a previously undescribed receptor-receptor interaction between the EphA4 ligand-binding and membrane-proximal fibronectin domains, which is functionally important for efficient receptor activation.


Subject(s)
Ephrin-A5/chemistry , Protein Structure, Tertiary , Receptor, EphA4/chemistry , Signal Transduction , Binding Sites/genetics , Blotting, Western , Crystallography, X-Ray , Enzyme Activation , Ephrin-A5/genetics , Ephrin-A5/metabolism , HEK293 Cells , Humans , Models, Molecular , Mutation , Protein Binding , Protein Conformation , Protein Multimerization , Receptor, EphA4/genetics , Receptor, EphA4/metabolism
4.
Proc Natl Acad Sci U S A ; 110(18): 7205-10, 2013 Apr 30.
Article in English | MEDLINE | ID: mdl-23592718

ABSTRACT

Angiogenesis is a complex cellular process involving multiple regulatory growth factors and growth factor receptors. Among them, the ligands for the endothelial-specific tunica intima endothelial receptor tyrosine kinase 2 (Tie2) receptor kinase, angiopoietin-1 (Ang1) and Ang2, play essential roles in balancing vessel stability and regression during both developmental and tumor-induced angiogenesis. Despite possessing a high degree of sequence identity, Ang1 and Ang2 have distinct functional roles and cell-signaling characteristics. Here, we present the crystal structures of Ang1 both unbound and in complex with the Tie2 ectodomain. Comparison of the Ang1-containing structures with their Ang2-containing counterparts provide insight into the mechanism of receptor activation and reveal molecular surfaces important for interactions with Tie2 coreceptors and associated signaling proteins. Using structure-based mutagenesis, we identify a loop within the angiopoietin P domain, adjacent to the receptor-binding interface, which confers the specific agonist/antagonist properties of the molecule. We demonstrate using cell-based assays that an Ang2 chimera containing the Ang1 loop sequence behaves functionally similarly to Ang1 as a constitutive Tie2 agonist, able to efficiently dissociate the inhibitory Tie1/Tie2 complex and elicit Tie2 clustering and downstream signaling.


Subject(s)
Angiopoietin-1/chemistry , Angiopoietin-1/metabolism , Signal Transduction , Angiopoietin-2/chemistry , Angiopoietin-2/metabolism , Conserved Sequence , Crystallography, X-Ray , HEK293 Cells , Humans , Models, Molecular , Protein Structure, Tertiary , Receptor, TIE-1/chemistry , Receptor, TIE-1/metabolism , Receptor, TIE-2/chemistry , Receptor, TIE-2/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Static Electricity , Structure-Activity Relationship
5.
Nat Struct Mol Biol ; 13(6): 524-32, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16732286

ABSTRACT

The Tie receptor tyrosine kinases and their angiopoietin (Ang) ligands play central roles in developmental and tumor-induced angiogenesis. Here we present the crystal structures of the Tie2 ligand-binding region alone and in complex with Ang2. In contrast to prediction, Tie2 contains not two but three immunoglobulin (Ig) domains, which fold together with the three epidermal growth factor domains into a compact, arrowhead-shaped structure. Ang2 binds at the tip of the arrowhead utilizing a lock-and-key mode of ligand recognition-unique for a receptor kinase-where two complementary surfaces interact with each other with no domain rearrangements and little conformational change in either molecule. Ang2-Tie2 recognition is similar to antibody-protein antigen recognition, including the location of the ligand-binding site within the Ig fold. Analysis of the structures and structure-based mutagenesis provide insight into the mechanism of receptor activation and support the hypothesis that all angiopoietins interact with Tie2 in a structurally similar manner.


Subject(s)
Angiopoietin-2/chemistry , Receptor, TIE-2/chemistry , Amino Acid Sequence , Calcium/chemistry , Calcium/metabolism , Chromatography, Gel , Crystallography, X-Ray , Epidermal Growth Factor/chemistry , Fibrinogen/chemistry , Models, Molecular , Molecular Sequence Data , Protein Binding , Protein Conformation , Receptor, TIE-2/metabolism , Sequence Homology, Amino Acid
6.
Protein Sci ; 15(8): 2008-13, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16823037

ABSTRACT

The advent of the multiwavelength anomalous diffraction phasing method has significantly accelerated crystal structure determination and has become the norm in protein crystallography. This method allows researchers to take advantage of the anomalous signal from diverse atoms, but the dominant method for derivative preparation is selenomethionine substitution. Several generally applicable, high-efficiency labeling protocols have been developed for use in the bacterial, yeast, and baculovirus/insect cell expression systems but not for mammalian tissue culture. As a large number of proteins of biomedical importance can only be produced in yields sufficient for X-ray diffraction experiments in mammalian expression systems, it becomes all the more important to develop such protocols. We therefore evaluated several variables that play roles in determining incorporation levels and report here a simple protocol for selenomethionine modification of proteins in mammalian cells routinely yielding >90% labeling efficiency.


Subject(s)
Amino Acid Substitution , Crystallography, X-Ray/methods , Recombinant Proteins/biosynthesis , Selenomethionine/metabolism , Staining and Labeling/methods , Cell Culture Techniques/methods , Cell Line , Crystallization , Culture Media , Humans , Receptor, TIE-2/biosynthesis , Recombinant Proteins/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
7.
Science ; 344(6189): 1275-9, 2014 Jun 13.
Article in English | MEDLINE | ID: mdl-24876346

ABSTRACT

Netrins are secreted proteins that regulate axon guidance and neuronal migration. Deleted in colorectal cancer (DCC) is a well-established netrin-1 receptor mediating attractive responses. We provide evidence that its close relative neogenin is also a functional netrin-1 receptor that acts with DCC to mediate guidance in vivo. We determined the structures of a functional netrin-1 region, alone and in complexes with neogenin or DCC. Netrin-1 has a rigid elongated structure containing two receptor-binding sites at opposite ends through which it brings together receptor molecules. The ligand/receptor complexes reveal two distinct architectures: a 2:2 heterotetramer and a continuous ligand/receptor assembly. The differences result from different lengths of the linker connecting receptor domains fibronectin type III domain 4 (FN4) and FN5, which differs among DCC and neogenin splice variants, providing a basis for diverse signaling outcomes.


Subject(s)
Axons/physiology , Membrane Proteins/chemistry , Nerve Growth Factors/chemistry , Receptors, Cell Surface/chemistry , Tumor Suppressor Proteins/chemistry , Animals , Cell Movement , DCC Receptor , Fibronectins/chemistry , Ligands , Membrane Proteins/genetics , Membrane Proteins/ultrastructure , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Nerve Growth Factors/genetics , Nerve Growth Factors/ultrastructure , Netrin Receptors , Netrin-1 , Neurons/physiology , Protein Multimerization , Protein Structure, Tertiary , Receptors, Cell Surface/genetics , Receptors, Cell Surface/ultrastructure , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL